Acelostat P Tab
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
₹60
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated August 2026
Medicines with the same active ingredient and strength as Ziasit-D 100/10MG Tab 10S.
You are viewing
Ziasit-D 100/10MG Tab 10S
tablet - 10 S
₹140
₹14.00 per tablet
UNISON PHARMACEUTICALS · tablet - 100 mg - 10 S · Rx
₹67
₹6.68 per tablet
SYSTOPIC LAB · tablet - 10 S · Rx
₹117
₹11.72 per tablet
Sitagliptin 100 mg + Dapagliflozin 10 mg
Type 2 diabetes mellitus: to improve glycaemic control in adults as an adjunct to diet and exercise when treatment with both agents is appropriate.
Sitagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), enhancing glucose-dependent insulin release and reducing glucagon. Dapagliflozin is an SGLT2 inhibitor that reduces renal glucose reabsorption, increasing urinary glucose excretion and lowering blood glucose.
Oral tablet; typically taken once daily as prescribed. Can be taken with or without food; take at the same time each day. Swallow whole with water; do not crush/chew. Dose adjustments may be needed in kidney impairment—follow doctor’s advice.
Common side effects of Ziasit-D 100/10MG Tab 10S may include:
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 200 mg - 10 S
Standard delivery
IPCA LABORATORIES LTD` · tablet - 100 mg - 10 S · Rx
₹130
₹12.99 per tablet
A substitute contains the same active ingredient (salt), in the same strength, as Ziasit-D 100/10MG Tab 10S. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Not for type 1 diabetes or diabetic ketoacidosis. Risk of dehydration/hypotension—ensure adequate fluids, especially in elderly or with diuretics. SGLT2 inhibitors may rarely cause ketoacidosis even with near-normal sugars—seek urgent care for nausea/vomiting, abdominal pain, rapid breathing. Increased risk of genital mycotic infections and UTIs; maintain hygiene and report symptoms. Monitor kidney function before and during therapy; avoid/initiate with caution in significant renal impairment as per prescriber. Rare risk of pancreatitis with sitagliptin—stop and seek care if severe persistent abdominal pain. Risk of hypoglycaemia when used with insulin or sulfonylureas—dose reduction of those agents may be required. Inform doctor before surgery/fasting; medicine may be temporarily stopped.